Clinical Trial Update: A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody [Phase 3]

View source ↗

Summary

A Phase 3 single-center trial evaluating enrotinib combined with a paclitaxel monoclonal antibody for advanced non-small cell lung cancer with positive EGFR mut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Enrotinib (enrotinib)
• Pianzumab (pianzumab)

Snippet

Sponsor: Degan Lu | Conditions: Lung Cancer, TKI Resistance | Phase 3 | Status: NOT_YET_RECRUITING